Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

12 Apr 2019 08:43

RNS Number : 0331W
Sabre Insurance Group PLC
12 April 2019
Β 

12 April 2019

Β 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Β 

Awards under the Company's Deferred Bonus Plan

The Company announces that on 11 April 2019 the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Deferred Bonus Plan, each granted a conditional award (the 'DBP Award') of ordinary shares of Β£0.001 in the Company, in respect of bonuses earned for the financial year ended 31 December 2018 as detailed below:

Β 

Name

Position

Number of shares subject to award

Geoff Carter

Chief Executive Officer

50,421

Adam Westwood

Chief Financial Officer

28,362

Trevor Webb

Claims Director

35,021

James Ockenden

Chief Actuary

31,513

Β 

Subject to the rules of the Sabre 2017 Deferred Bonus Plan, the DBP Awards will vest on the second anniversary of the grant date.

Β 

Awards under the Company's Long Term Incentive Plan

The Company further announces that on 11 April 2019 the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Long Term Incentive Plan, each granted a conditional award (the 'LTIP Award') of ordinary shares of Β£0.001 in the Company as detailed below:

Β 

Name

Position

Number of shares subject to award

Geoff Carter

Chief Executive Officer

183,575

Adam Westwood

Chief Financial Officer

86,388

Trevor Webb

Claims Director

112,305

James Ockenden

Chief Actuary

103,666

Anneka Kingan

Company Secretary

65,655

Β 

The vesting of the awards will be subject to the achievement of performance conditions measuring the Company's total shareholder return performance (relative to the constituent companies of the FTSE250 index (excluding investment trusts and companies in the extractive industries)) and earnings per share performance, both measured over a period from 1 January 2019 to 31 December 2021. Subject to the rules of the Sabre 2017 Long Term Incentive Plan, the LTIP Awards will vest on the second Dealing Day after the Board determines the extent to which the performance conditions have been satisfied. Any shares acquired by a director, following the vesting and release of an LTIP Award will be subject to an additional retention period of two years, commencing on the award's vesting date.

Β 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.ukΒ 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Geoff Carter

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

50,421

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

50,421

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Adam Westwood

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

28,362

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

28,362

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Trevor Webb

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Claims Director

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

35,021

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

35,021

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

James Ockenden

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Actuary

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Deferred Bonus Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

31,513

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

31,513

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Geoff Carter

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

183,575

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

183,575

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Adam Westwood

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

86,388

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

86,388

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Trevor Webb

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Claims Director

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

112,305

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

112,305

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

James Ockenden

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Actuary

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

103,666

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

103,666

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

Β 

Β 

Β 

Β 

PDMR transaction notification

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Anneka Kingan

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Company Secretary

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Sabre Insurance Group Plc

b)

Β 

LEI

Β 

2138006RXRQ8P8VKGV98

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

Β 

Nature of the transaction

Β 

Β 

Grant of conditional award

c)

Β 

Price(s) and volume(s)

Β 

Price per share

Volume

Β£2.894

65,655

d)

Aggregated Information

Volume

Price

Β 

Volume

Price per share

65,655

Β£2.894

Β 

e)

Date of transaction

11 April 2019

f)

Place of transaction

London Stock Exchange (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHDLLBFKZFZBBF
Date   Source Headline
2nd Jun 20267:00 amRNSOn-market Share Buyback Programme of £5m
27th May 20269:36 amRNSDirector Declaration
21st May 202611:20 amRNSResult of AGM
21st May 20267:00 amRNSTrading Update
12th May 20261:22 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
14th Apr 20263:48 pmRNSDirector/PDMR Shareholding
13th Apr 20263:18 pmRNSDirector/PDMR Shareholding
8th Apr 20262:56 pmRNSDirector/PDMR Shareholding
8th Apr 202610:41 amRNSDirector/PDMR Shareholding
8th Apr 202610:39 amRNSDirector/PDMR Shareholding
30th Mar 202611:01 amRNSNotice of AGM
11th Mar 20261:49 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSFull-year results 2025
11th Feb 20261:27 pmRNSDirector/PDMR Shareholding
13th Jan 20263:43 pmRNSDirector/PDMR Shareholding
11th Dec 20251:29 pmRNSDirector/PDMR Shareholding
11th Nov 20251:40 pmRNSDirector/PDMR Shareholding
31st Oct 20258:00 amRNSTotal Voting Rights
23rd Oct 20259:58 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTrading Update
14th Oct 20257:49 amRNSHolding(s) in Company
13th Oct 20253:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20257:00 amRNSCompletion of Buyback Programme
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 202510:21 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20251:01 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20254:52 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 202512:24 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.